Latest Biotechnology, Pharmaceutical and Healthcare News from OBN
Here are the most relevant search results for "OBN" found in our extensive news archives from over 250 global news sources.
More Information about OBN on BioPortfolio
In addition to our news stories we have dozens of PubMed Articles about OBN for you to read. Along with our medical data and news we also list OBN Clinical Trials, which are updated daily. BioPortfolio also has a large database of OBN Companies for you to search.
Showing News Articles 1–25 of 364 from OBN
InterPharm Investments appoints Danilo Casadei Massari to Board of Directors (News)
22 May 2013: London, UK – InterPharm Investments Ltd, a ‘search and development' company focused on Medical Foods, today announced that Danilo Casadei Massari has joined the Board ...
22 May 2013: Oxford, UK – Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has initiated a Phase 2 clinical study ...
21 May 2013: London, UK – Connect Digital Health, organisers of the forthcoming Digital Health Forum 2013 (DHF13) to be held in London on 11 June, has launched its ‘Hot 5' ...
20 May 2013: Oxford, UK - PhosphonicS Ltd, a leading precious metal recovery specialist, today announced the appointment of Dr Linda Bell as chief executive officer with immediate effect. ...
The Babraham Institute Announces the Formation of Babraham Commercialisation Services Ltd (News)
20 May 2013: Cambridge, UK - The Babraham Institute has announced the formation of a new wholly-owned trading arm, Babraham Commercialisation Services Ltd (BCS), to support its Knowledge Exchange and ...
BioTrinity Ventures to the Capital (News)
16 May 2013: London, UK - First patient enrolled in Phase III clinical trial for moxetumomab pasudotox as a treatment for unresponsive or relapsed hairy cell leukaemia patients. Olaparib planned to ...
Almac Secures New Metagenomics and Enzyme Discovery Programme with UCL (News)
15 May 2013: Craigavon, UK - The Almac biocatalysis group has secured a prestigious BBSRC (Biotechnology and Biological Sciences Research Council) programme with UCL focused specifically on ...
10 May 2013: Oxford, UK – Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, has today announced the development of a ...
Oval Insurance Broking Becomes OBN's Dedicated Insurance Broker of Choice (News)
09 May 2013: Oxford, UK – OBN, the trade association supporting and bringing together the UK's emerging life science R&D companies, their corporate partners and their investors, are ...
08 May 2013: Oxford, UK - Oxford Pharmascience, the specialty pharmaceutical company that uses advanced pharmaceutic technologies to make medicines better, safer and easier to take, today announces ...
07 May 2013: Newcastle & Nottingham, UK - Aesica, the global contract manufacturing organisation (CMO), announces a partnership with the University of Nottingham for the commercial development of ...
07 May 2013: Edinburgh & Glasgow, UK - ClinTec International and Edinburgh Napier University are proud to announce the launch of the ‘Masters in International Clinical Research and ...
Aeras, University of Oxford, Okairos: TB, HIV and Malaria Vaccine Research Gets Major Boost (News)
Rockville, USA & Oxford, UK & Basel, Switzerland - Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company ...
Academy of Medical Sciences Honours Seven Oxford Researchers (News)
07 May 2013: Oxford, UK - Seven medical researchers at Oxford University have been elected as Fellows of the Academy of Medical Sciences. Professors Barbara Casadei, Michael English, Russell Foster, ...
03 May 2013: Cambridge, UK - F-star, a biopharmaceutical company focused on developing novel bispecific antibody products, today announced the company has received a Biomedical Catalyst ...
03 May 2013: Oxford, UK - The Prime Minister, David Cameron, was at Oxford University today to mark the launch of a centre that will put the UK at the forefront of revolutionising healthcare through ...
OBN's Call for Biomedical Catalyst Extension Backed by Industry Heavyweights (News)
03 May 2013: Abingdon, UK - OBN, the trade association supporting and bringing together the UK's emerging life sciences companies, their corporate partners and investors, has welcomed the ...
Immunocore announces appointment of Eva-Lotta Allan to the Board (News)
02 May 2013: Oxford, UK - Immunocore Limited, the Oxford-based biotechnology company developing novel drugs to treat cancer and viral disease, today announced the appointment of Eva-Lotta Allan ...
01 May 2013: Raleigh, USA & Cambridge, UK - ImmunoReagents, the global manufacturer of high quality antibody products to the diagnostic and research industry, has entered into a ...
Oxford BioMedica Announces Lentiviral Vector Development and Manufacturing Collaboration (News)
01 May 2013: Oxford, UK – Oxford BioMedica plc announced that it has signed an agreement with Novartis to manufacture clinical grade material utilising Oxford BioMedica's ...
01 May 2013: Philadelphia, USA – Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the prescription medication ...
30 April 2013: San Diego, California, USA and Oxford, UK – Glide Pharma today announced the award of a sub-contract from Pfenex Inc. to develop a solid formulation containing the ...
